Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors

By Liang Yayun  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 407-420

Springer Publishing Company

Access to resources Recommend Favorite

huBC1-IL12, an immunocytokine which targets EDB-containing oncofetal fibronectin in tumors and tumor vasculature, shows potent anti-tumor activity in human tumor models

By Lo Kin-Ming   Lan Yan   Lauder Scott   Zhang Jinyang   Brunkhorst Beatrice   Qin Guozhong   Verma Rakesh   Courtenay-Luck Nigel   Gillies Stephen  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 4, 2007-04 ,pp. : 447-457

Springer Publishing Company

Access to resources Recommend Favorite

Abrogation Of Tumor Vasculature Using Gene Therapy

By Nesbit M.  

Cancer and Metastasis Reviews, Vol. 19, Iss. 1-2, 2000-06 ,pp. : 45-49

Springer Publishing Company

Access to resources Recommend Favorite

Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model

By Iankov Ianko   Msaouel Pavlos   Allen Cory   Federspiel Mark   Bulur Peggy   Dietz Allan   Gastineau Dennis   Ikeda Yasuhiro   Ingle James   Russell Stephen   Galanis Evanthia  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 745-754

Springer Publishing Company

Access to resources Recommend Favorite

Improved Anti-Tumor Activity of Novel Highly Bioactive Liposome-Bound TRAIL in Breast Cancer Cells

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 2, 2016-04 ,pp. : 197-214

Bentham Science Publishers

Access to resources Recommend Favorite